June 13, 2014 09:55 UTC

Research and Markets: Ovarian Cancer Treatment Drugs Markets in China: Updated 2014 Report

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/phdzxc/ovarian_cancer) has announced the addition of the "Ovarian Cancer Treatment Drugs Markets in China: Updated 2014 Report" report to their offering.

China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented.

Major producers in China are profiled. A selection of these companies can be seen in the 'Companies Mentioned' tab. The full list can be viewed upon purchase of the report.

Key Topics Covered:

I. INTRODUCTION

II. BUSINESS ENVIRONMENT

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

Ovarian Cancer Treatment Drugs Markets Outlook Overview

Government Regulation

Health Care Insurance Industry Overview

Consumer Spending Trends

Demographic Trends

Health Care Industry Trends

Hospitals and Hospital Beds

Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

China Market Entry Overview

China's Distribution System

Ovarian Cancer Treatment Drugs Distribution Channels

Transportation and Freight Infrastructure

Communications

China's Market Entry

Licensing

Franchising

E-commerce

Trading Companies and Local Agents

Representative Offices and Chinese Subsidiaries

Wholly Foreign Owned Enterprises

VII. OVARIAN CANCER TREATMENT DRUGS PRODUCER DIRECTORY

Ovarian Cancer Treatment Drugs Producer Profiles and Directory

Companies Mentioned:

  • Harbin Pharmaceutical Group Bioengineering Co., Ltd
  • Beijing Union Pharmaceutical Factory

For more information visit http://www.researchandmarkets.com/research/phdzxc/ovarian_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Ovarian Cancer


Source: Research and Markets